Hypotensive activity of Campomanesia xanthocarpa leaf extract: beyond angiotensin II type 1 receptor blockage

Nat Prod Res. 2021 Nov;35(22):4798-4802. doi: 10.1080/14786419.2020.1727467. Epub 2020 Feb 21.

Abstract

The ability of Campomanesia xanthocarpa leaf extract (CXLE) to alter blood pressure and heart rate was evaluated in anesthetized rats. The CXLE-induced hypotension was evaluated before and after losartan, methylatropine, L-N(ω)-nitro-L-arginine methyl ester (L-NAME), hexamethonium, indomethacin, glibenclamide, or nifedipine administration. The constituents of CXLE were identified by LC-DAD-MS. CXLE decreased blood pressure in a dose-dependent manner; only the highest dose decreased heart rate. The hypotension induced by CXLE was sensitive only to losartan, nifedipine, and glibenclamide. L-NAME decreased the time to recover 50% of the hypotensive effect of CXLE without altering its magnitude. Flavan-3-ols, proanthocyanidins (dimers and trimers), and glycosylated flavonols were identified from CXLE. The chemical constituents of CXLE seem to induce not only angiotensin II type 1 receptor blockage, but also ATP-sensitive potassium channels activation and L-type voltage-dependent Ca2+ channels inactivation. Nitric oxide is involved in the maintenance of the hypotensive effect of CXLE.

Keywords: Cardiovascular; calcium channels; flavan-3-ols; glycosylated flavonols; potassium channels; proanthocyanidins.

MeSH terms

  • Animals
  • Blood Pressure
  • Hypotension*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide
  • Plant Extracts / pharmacology
  • Rats
  • Receptor, Angiotensin, Type 1*

Substances

  • Plant Extracts
  • Receptor, Angiotensin, Type 1
  • Nitric Oxide
  • NG-Nitroarginine Methyl Ester